Navigation Links
Media Advisory: ACC Updated Schedule

Schering-Plough Announces Presentation Of Phase II Trial Results For Novel Oral Thrombin Receptor Antagonist At The 2007 Annual Meeting Of The American College Of Cardiology/i2 Summit

KENILWORTH, N.J., March 16, 2007 /PRNewswire-FirstCall/ -- Schering-Plough Corporation announced today that results of the Phase II trial of its novel oral thrombin receptor antagonist (TRA) SCH 530348 will be presented at the 2007 annual Scientific Sessions of the of Cardiology (ACC.07)/Innovation in Intervention (i2) Summit, March 24-27 in New Orleans. The Phase II trial, referred to as the Thrombin Receptor Antagonist in Percutaneous Coronary Intervention (TRA-PCI) trial, has been accepted as a late-breaker presentation.

The trial was designed to evaluate the safety and tolerability of Schering-Plough's TRA coadminstered with standard of care antithrombotic therapy (including aspirin and clopidogrel) in patients undergoing percutaneous coronary intervention (PCI). A secondary objective was to assess whether patients treated with the compound had fewer cardiovascular events such as heart attack, need for urgent coronary revascularization, or death at 60 days compared with patients treated with the standard of care.

TRA Late-Breaker Trial Data Presentation:

Results of a Multinational Randomized, Double-Blind, Placebo-Controlled Study of a Novel Thrombin Receptor Antagonist SCH 530348 in Percutaneous Coronary Intervention, David J. Moliterno, MD, Chief of Cardiovascular Medicine, University of Kentucky School of Medicine, for the TRA-PCI Investigators, Saturday, March 24, 11:45AM - 11:55AM, Ernest N. Morial Convention Center, La Nouvelle Orleans C.

Dr. Moliterno will participate in the ACC press conference immediately following (12:00PM - 1:00PM) in Rooms 215-216, just above Hall A.

About Schering-Plough Corporation

Schering-Plough is a global science-based health care company with leading
'"/>




Page: 1 2

Related medicine technology :

1. Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
2. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
3. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
4. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
5. Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
6. Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II trial of Cloretazine (VNP40101M) in Patients with Relapsed or Refractory Small Cell Lung Cancer
7. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
8. Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia Long-Term Safety Data at AAN Annual Meeting
9. Boston Scientific Announces Schedule for EuroPcr 2007

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Media Advisory ACC Updated Schedule
(Date:12/1/2009)... , TAI,AN, China, Dec. 1 /PRNewswi.... (OTC Bulletin Board: CBPO) (Nasdaq: CBPO ) ("Ch...ng plasma-based biopharmaceutical companies in,Chi...approval to list its,common stock on the NASDAQ Gl... shares to begin trading on the NASDAQ on,Wednesda...
(Date:12/1/2009)... , BEIJING, Dec. 1 /PRNewswire-Asia/... provider of biopharmaceutical products in China, ...rchase order for its H1N1 vaccine, PANFLU.1(TM),f...echnology for the national,purchase plan. Under th...an,additional one million doses of PANFLU.1 (TM) (...
(Date:12/1/2009)... , ROCKVILLE, Md., Dec. 1 /PRNewswire-FirstCal...announced today that the waiting period has expire...ovements Act of 1976 with respect to Vanda,s agree... AG, and that the agreement is now effective. Exp...ffectiveness of the agreement, triggers an upfront...
Breaking Medicine Technology:China Biologic Products Approved to List on NASDAQ 2China Biologic Products Approved to List on NASDAQ 3Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3New method monitors early sign of oxidative stress in cancer 9886 1New method monitors early sign of oxidative stress in cancer 9886 2When proteins change partners 9884 1When proteins change partners 9884 2Nuvilex Inc Announces Reme Flu 28TM 29 as Trade Name for All Natural Flu Remedy Formula 56936 1Nuvilex Inc Announces Reme Flu 28TM 29 as Trade Name for All Natural Flu Remedy Formula 56936 2Nuvilex Inc Announces Reme Flu 28TM 29 as Trade Name for All Natural Flu Remedy Formula 56936 3
...nificance of AHCC for maintaining a healthy immune...blished study in Nutrition and Cancer (60(5), 64... in Osaka, Japan has shown that AHCC (Active Hexos... increasing the number of dendritic cells (DCs). D... for presenting foreign substances to other immune...
...Jan. 6 The Michael J. Fox Foundation awarded a to...h teams for pre-clinical research on potential new...ing was awarded under the Foundation,s Therapeuti...unched in 2006, supports and bolsters industry-foc...t of MJFF,s focus on ,de-risking, preclinical PD...
Other Medicine Technology:Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2
(Date:12/1/2009)..., SOUTHFIELD, Mich., Dec. 1 /PRNewswire-FirstCa...: FMR ) ("First Mercury" or the "Company") annou...Directors declared a quarterly cash dividend of $0...areholders of record at the close of business on D...ancial Corporation ,, First Mercury Financial ...
(Date:12/1/2009)...es H1N1 vaccination because pandemic,s course rema...ealthDay News) -- A U.S. health official said Tues... the wane nationally, but many experts agreed the ..., The flu is now widespread in 32 states -- down f...en, director of the U.S. Centers for Disease Contr...
(Date:12/1/2009)... , RESEARCH TRIANGLE PARK, N.C., Dec. 1 /PRNe...ated in 2001 and have expanded over the years serv.... The facility which was originally set up in an a...acy services, as part of the suite of services by ...dustry as a valuable offering. ,, The pharmacy ...
(Date:12/1/2009)..., WASHINGTON, Dec. 1 ... for International Development: ,, Chairman Ker...ttee. ,, I am honored to be nominated by Presid...States Agency for International Development, and I...y. ,, Secretary of State Clinton has expressed...
(Date:12/1/2009)...mber 1, 2009) The ADEAGies Foundation will honor ...ent Award at the Gies Awards celebration to be hel...unction with the 2010 ADEA Annual Session & Exhibi...ation, and Achievement recognize contributions to,...nitiatives. For a complete listing of Gies Award w...
Breaking Medicine News(10 mins):Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 4Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 5Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 6Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 7Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 8Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 9Health News:The Forsyth Institute receives the William J. Gies Award for outstanding achievement 2
...d with 360 Health & Safety Violations, SALINAS, C...yline Care Center and Windsor Ridge Care Center wi... employer to make needed,improvements in resident ...ing homes operated by Windsor,Healthcare., Since ...
...se in number of people dying after mixing meds, il...y News) -- Researchers have discovered a soaring i...hat occur in people,s homes. , The report inciden...rtment in New York City. , "[There was] large-scal...
... The innovative CHA Women,s and,Children,s Hospita...y four,projects worldwide to win the 2008, prestig...al Healthcare Design Award. It is one of the more,...CHA Hospital coupled with this esteemed award furt...
...ji Healthcare, Inc.,(OTC Bulletin Board: TONJ), a ...services in China, announced that it has engaged G...ttp://www.dr-petri-hc.de/ ) to,complete their Lang...ral and operational plans to,incorporate additiona...
..., ACTON, Mass., July 28 Psychemedics,Corporation...ncial results,for the period ended June 30, 2008. ... $0.17 per share payable to shareholders of record...ter revenue was $6.2 million, down 4% as,compared ...
...ust about body aches and pains. As we get older, o...n,t heal like young ones, and for senior citizens,...chers at Tel Aviv University provide hopeful news ...o. Older people who take methylphenidate (the gene...
Other Medicine News:Health News:Caregivers at 8 Bay Area Nursing Homes Protest Unsafe Resident Conditions in Salinas 2Health News:Accidental Overdoses in the Home Soaring 2Health News:Accidental Overdoses in the Home Soaring 3Health News:Accidental Overdoses in the Home Soaring 4Health News:KMD's CHA Hospital, Korea Wins 2008 AIA National Healthcare Award 2Health News:Tongji Hires German Based Dr. Petri Consulting GmbH for Langdong Project 2Health News:Psychemedics Corporation Announces Second Quarter Results 2Health News:Psychemedics Corporation Announces Second Quarter Results 3Health News:Psychemedics Corporation Announces Second Quarter Results 4Health News:Psychemedics Corporation Announces Second Quarter Results 5Health News:Alleviating the fear of falling 2
The LITE STYLE
Jarrod Goggle
Full Field Viewing Mask
...th gold electro-plate, the flex-temple spring hing...justable non-slip silicon nose pads for maximum co...lead sheet side shields that create a seal to the ...ction. (Temples on this model do not have spring h...
Medicine Products: